Expectations and Beliefs of Transgender People Regarding Hormonal Treatment

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05474768

Enrollment

Registered

2022-07-26

Start date

2022-02-02

Completion date

2023-01-31

Last updated

2022-07-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transgenderism

Brief summary

Hormonal treatment of gender dysphoria can have repercussions on metabolism, cardiovascular system and fertility and represents à potential oncological risk. According to the recommendations of the Endocrine society. Therefore, initial assessment and follow-up visits are necessary and must be carried out to avoid the apparition of potentially undesirable effects.

Interventions

OTHERno intervention

no intervention

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* being a parent of adolescent/child presenting Gender dysphoria * adult subject (age \> 18 years) presenting Gender dysphoria non-inclusion criteria * Severe, uncontrolled psychiatric or somatic illness * Chronic alcoholism * Substance abuse * Refusal or linguistic, physical or psychological incapacity to participate in the study * Ongoing pregnancy

Design outcomes

Primary

Measure	Time frame	Description
Describe expectations and beliefs of transgener people about hormonal therapy	12 months	qualitative analysis of qualitative data from collective discussions (focus groups)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026